Abdullah A. Osman

3.7k total citations · 1 hit paper
36 papers, 2.1k citations indexed

About

Abdullah A. Osman is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Abdullah A. Osman has authored 36 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 16 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Abdullah A. Osman's work include Cancer-related Molecular Pathways (14 papers), interferon and immune responses (6 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Abdullah A. Osman is often cited by papers focused on Cancer-related Molecular Pathways (14 papers), interferon and immune responses (6 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Abdullah A. Osman collaborates with scholars based in United States, China and Japan. Abdullah A. Osman's co-authors include Lawrence J. Mandarino, Thongchai Pratipanawatr, Kenneth Cusi, Merri Pendergrass, Katsumi Maezono, Ralph A. DeFronzo, C. Ronald Kahn, Mary‐Elizabeth Patti, Jeffrey N. Myers and Ameeta A. Patel and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Abdullah A. Osman

35 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Insulin resistance differentially affects the PI 3-kinase– and MAP kinase–mediated signaling in human muscle

2000 856 citations Kenneth Cusi, Katsumi Maezono et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Abdullah A. Osman United States	19	1.2k	480	420	266	247	36	2.1k
Alan Cheng United States	26	1.9k 1.6×	593 1.2×	562 1.3×	222 0.8×	350 1.4×	45	3.1k
Marcus D. Goncalves United States	21	1.5k 1.3×	423 0.9×	733 1.7×	545 2.0×	275 1.1×	64	2.5k
Akiko Kimura Japan	26	1.4k 1.2×	545 1.1×	282 0.7×	366 1.4×	166 0.7×	49	2.4k
Jingyi Gong United States	20	1.0k 0.9×	451 0.9×	613 1.5×	146 0.5×	266 1.1×	35	2.3k
Christopher N Hahn Australia	28	1.2k 1.0×	252 0.5×	297 0.7×	271 1.0×	125 0.5×	72	2.2k
Na Niu China	25	834 0.7×	438 0.9×	227 0.5×	378 1.4×	260 1.1×	103	2.1k
Albina Nesterova United States	14	995 0.9×	603 1.3×	211 0.5×	187 0.7×	128 0.5×	24	1.9k
Richard T. Waldron United States	32	2.0k 1.7×	599 1.2×	258 0.6×	233 0.9×	284 1.1×	63	3.2k
Elena Rapizzi Italy	25	1.4k 1.2×	388 0.8×	261 0.6×	606 2.3×	291 1.2×	61	2.5k
Françoise Bono France	29	1.3k 1.1×	380 0.8×	174 0.4×	404 1.5×	133 0.5×	65	2.7k

Countries citing papers authored by Abdullah A. Osman

Since Specialization

Citations

This map shows the geographic impact of Abdullah A. Osman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdullah A. Osman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdullah A. Osman more than expected).

Fields of papers citing papers by Abdullah A. Osman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdullah A. Osman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdullah A. Osman. The network helps show where Abdullah A. Osman may publish in the future.

Co-authorship network of co-authors of Abdullah A. Osman

This figure shows the co-authorship network connecting the top 25 collaborators of Abdullah A. Osman. A scholar is included among the top collaborators of Abdullah A. Osman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdullah A. Osman. Abdullah A. Osman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pifer, Phillip M., Liangpeng Yang, Manish Kumar, et al.. (2023). FAK Drives Resistance to Therapy in HPV-Negative Head and Neck Cancer in a p53-Dependent Manner. Clinical Cancer Research. 30(1). 187–197. 13 indexed citations

Osman, Abdullah A., Emre Arslan, Chieko Michikawa, et al.. (2023). Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 29(7). 1344–1359. 32 indexed citations

Shi, Yewen, Xiaoyong Ren, Shaolong Cao, et al.. (2023). TP53 gain-of-function mutation modulates the immunosuppressive microenvironment in non-HPV-associated oral squamous cell carcinoma. Journal for ImmunoTherapy of Cancer. 11(8). e006666–e006666. 16 indexed citations

Rangel, Roberto, et al.. (2023). 1494 Role of gain of function p53 mutations in macrophage polarization and myeloid-derived suppressor cells in head and neck squamous cell carcinoma. SHILAP Revista de lepidopterología. A1658–A1658. 1 indexed citations

Shi, Yewen, Tongxin Xie, Bingbing Wang, et al.. (2022). Mutant p53 drives an immune cold tumor immune microenvironment in oral squamous cell carcinoma. Communications Biology. 5(1). 757–757. 24 indexed citations

Michikawa, Chieko, Pedro A. Torres‐Saavedra, Natalie L. Silver, et al.. (2022). Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234. Advances in Radiation Oncology. 7(6). 100989–100989. 3 indexed citations

Lindemann, Antje, Ameeta A. Patel, Lin Tang, et al.. (2021). Combined Inhibition of Rad51 and Wee1 Enhances Cell Killing in HNSCC Through Induction of Apoptosis Associated With Excessive DNA Damage and Replication Stress. Molecular Cancer Therapeutics. 20(7). 1257–1269. 18 indexed citations

Spiotto, Michael T., Cullen M. Taniguchi, Ann H. Klopp, et al.. (2021). Biology of the Radio- and Chemo-Responsiveness in HPV Malignancies. Seminars in Radiation Oncology. 31(4). 274–285. 21 indexed citations

Tanaka, Noriaki, Abdullah A. Osman, Yoko Takahashi, et al.. (2018). Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity. Oral Oncology. 87. 49–57. 106 indexed citations

10.

Tanaka, Noriaki, Mei Zhao, Lin Tang, et al.. (2017). Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1. Oncogene. 37(10). 1279–1292. 41 indexed citations

11.

Tanaka, Noriaki, Ameeta A. Patel, Jiping Wang, et al.. (2015). Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins. Clinical Cancer Research. 21(21). 4831–4844. 46 indexed citations

12.

Osman, Abdullah A., Marcus M. Monroe, Marcus V. Ortega Alves, et al.. (2014). Wee-1 Kinase Inhibition Overcomes Cisplatin Resistance Associated with High-Risk TP53 Mutations in Head and Neck Cancer through Mitotic Arrest Followed by Senescence. Molecular Cancer Therapeutics. 14(2). 608–619. 88 indexed citations

13.

Lubis, Zulkarnain & Abdullah A. Osman. (2014). Indonesian tourism sector: a potential sector that has not been optimized.. AUSTRALIAN JOURNAL OF BASIC AND APPLIED SCIENCES. 8(23). 286–290. 4 indexed citations

14.

Yang, Liang, Alison L. Fitzgerald, Abdullah A. Osman, et al.. (2014). The p53-Reactivating Small Molecule RITA Induces Senescence in Head and Neck Cancer Cells. PLoS ONE. 9(8). e104821–e104821. 24 indexed citations

15.

Alves, Marcus V. Ortega, Curtis R. Pickering, Abdullah A. Osman, et al.. (2013). Chk1/2 Inhibition Overcomes the Cisplatin Resistance of Head and Neck Cancer Cells Secondary to the Loss of Functional p53. Molecular Cancer Therapeutics. 12(9). 1860–1873. 95 indexed citations

16.

Osman, Abdullah A., et al.. (2008). Muscle-like nicotinic receptor accessory molecules in sensory hair cells of the inner ear. Molecular and Cellular Neuroscience. 38(2). 153–169. 13 indexed citations

17.

Osman, Abdullah A., et al.. (2005). The Final Stage of Cholinergic Differentiation Occurs Below Inner Hair Cells During Development of the Rodent Cochlea. Journal of the Association for Research in Otolaryngology. 6(4). 401–415. 23 indexed citations

18.

Bao, Jianxin, Hana Lin, Yannan Ouyang, et al.. (2004). Activity-dependent transcription regulation of PSD-95 by neuregulin-1 and Eos. Nature Neuroscience. 7(11). 1250–1258. 135 indexed citations

19.

Osman, Abdullah A., Mitsuyoshi Saito, Carol M. Makepeace, et al.. (2003). Wolframin Expression Induces Novel Ion Channel Activity in Endoplasmic Reticulum Membranes and Increases Intracellular Calcium. Journal of Biological Chemistry. 278(52). 52755–52762. 158 indexed citations

20.

Cusi, Kenneth, Katsumi Maezono, Abdullah A. Osman, et al.. (2000). Insulin resistance differentially affects the PI 3-kinase– and MAP kinase–mediated signaling in human muscle. Journal of Clinical Investigation. 105(3). 311–320. 856 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact